I&#x27;ve never read her work, so I&#x27;m hardly parroting her. IIRC I&#x27;ve read about this in a few news articles about pharma finances, and in Ben Goldacre&#x27;s &quot;Bad Pharma&quot;. I don&#x27;t know whether the marketing&#x2F;sales figures include administration, but it does appear to be true, and I&#x27;d be inclined to think it&#x27;s bad...